Facial cosmetic surgery procedures, including facelifts and eyelid operations, are experiencing a significant increase across the United Kingdom, with clinicians pointing to side effects from popular weight-loss medications as a key driver. Newly released data from the British Association of Aesthetic Plastic Surgeons (BAAPS) indicates a notable 11 per cent rise in face and neck lifts, alongside an 8 per cent increase in eyelid surgeries over the past year.
The Impact of 'Ozempic Face' on Patient Demand
Surgeons report that the surge is largely attributed to a phenomenon colloquially known as "Ozempic face," which results from rapid weight loss induced by GLP-1 agonist drugs like Ozempic. These medications, while effective for weight management, can lead to a gaunt or prematurely aged appearance due to their impact on skin elasticity and collagen levels. As patients lose weight quickly, their facial skin may sag or lose volume, prompting many to seek surgical interventions to restore a more youthful contour.
Shifting Trends in Cosmetic Procedures
Conversely, demand for other types of cosmetic surgeries is declining. Breast augmentations and abdominoplasties, or tummy tucks, are seeing reduced interest, with a particularly sharp 38 per cent drop in superficial gluteal lipofilling (SGL) procedures. This shift suggests a growing preference among patients for achieving more natural body proportions and enhanced comfort, rather than focusing on dramatic alterations to their physique.
Influence of Social Media and Modern Perceptions
Social media platforms are also playing a crucial role in shaping perceptions of facial surgery, making procedures like facelifts and eyelid corrections more mainstream and acceptable. The visibility of before-and-after transformations online has demystified these operations, encouraging individuals to consider them as viable options for addressing the aesthetic side effects of weight-loss treatments.
Overall, the data highlights a dynamic change in the cosmetic surgery landscape, where the unintended consequences of pharmaceutical innovations are reshaping patient priorities and surgical trends in the UK.
